Position in MGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,132,641
+$6,346,863 QoQ
Shares Held
601,972
+191.9% QoQ
Ownership
0.627%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#24
of 157 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Derivatives in MGTX
reported options exposure · as of Jun 30, 2026CallValue
$1,118,628
CallShares
82,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. MGTX ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
This page
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in MGTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,118,628 | 82,800 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $8,132,641 | 601,972 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,785,778 | 206,210 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,541,511 | 319,687 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,821,662 | 1,800,931 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,330,622 | 2,044,574 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $69,764 | 10,700 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $1,041,408 | 153,600 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $7,856,399 | 1,158,761 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,655,871 | 271,900 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $3,352,666 | 550,520 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,583,193 | 859,279 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,641,580 | 389,924 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $819,450 | 135,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||